<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02918084</url>
  </required_header>
  <id_info>
    <org_study_id>GIM10-CONSENT</org_study_id>
    <secondary_id>2013-001629-23</secondary_id>
    <nct_id>NCT02918084</nct_id>
  </id_info>
  <brief_title>CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer</brief_title>
  <acronym>GIM10-CONSENT</acronym>
  <official_title>A Phase III Study Comparing the Concurrent Versus the Sequential Administration of Chemotherapy and Aromatase Inhibitors, as Adjuvant Treatment of Post-menopausal Patients With Endocrine-responsive Early Breast Cancer.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinical Research Technology S.r.l.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Breast cancer is the most common form of cancer among women. For patients candidated for
      adjuvant chemotherapy and endocrine therapy the optimal timing for their has not been clearly
      defined yet.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Breast cancer is the most common form of cancer among women in North America, Europe and
      Latin America. Because nearly 80% of breast cancers are endocrine-responsive tumors, the
      majority of patients candidates for adjuvant chemotherapy (CT) are also candidates for
      endocrine therapy (ET). The optimal timing (i.e. concomitant vs sequential administration)
      for the integration of these two treatments has not been clearly defined yet.

      In patients with hormone receptor positive early stage breast cancer who are candidates to
      adjuvant chemotherapy and endocrine therapy, the optimal timing for the integration of these
      two treatment modalities has not been clearly defined yet.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">June 2028</completion_date>
  <primary_completion_date type="Anticipated">June 2028</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disease- free Survival (DFS)</measure>
    <time_frame>up to 15 years</time_frame>
    <description>the primary outcome indicator will be the so called DFS, defined as time elapsing between the date of randomization and the date of one of the following events, whichever occurs first, assessed up to 15 years:
Local Recurrence of disease
Regional recurrence of disease
Distant recurrence of disease
Contralateral invasive or intraductal breast cancer
Second primary malignancy other than breast
Death for any cause</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall Survival (OS)</measure>
    <time_frame>time between the date of randomization up to the date of death for any cause, assessed up to 15 years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Translational Study: genomic analysis</measure>
    <time_frame>up to 15 years</time_frame>
    <description>Expression of genes associated with ER and Ki67 expression will be analyzed by Real Time polymerase chain reaction (PCR) on RNA extracted from formalin-fixed paraffin embedded (FFPE) sections of tumors classified as intermediate risk by clinical and pathological variables (stage I-II, G2, hormone receptors positive) and will be correlated with disease free survival.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Translational Study: epigenetic analysis</measure>
    <time_frame>up to 15 years</time_frame>
    <description>miRNA expression analysis by real time PCR and DNA methylation analysis by pyrosequencing will be assessed on FFPE sections of tumors classified as intermediate risk by clinical and pathological variables (stage I-II, G2, hormone receptors positive)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Translational Study: proteomic analysis</measure>
    <time_frame>up to 15 years</time_frame>
    <description>The different proteomic profiles identified in FFPE sections of hormone receptors positive G2 tumors will be correlated with DFS</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>ARM A</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Adjuvant chemotherapy → Aromatase inhibitors x 5 yrs (sequential arm)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ARM B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adjuvant chemotherapy + Aromatase inhibitors x 5 yrs (concurrent arm)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Anastrozole or Letrozole or Exemestane</intervention_name>
    <description>Adjuvant chemotherapy → Anastrozole or Letrozole or Exemestane once a day for 5 years (sequential arm)</description>
    <arm_group_label>ARM A</arm_group_label>
    <other_name>Clinical Practice</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Anastrozole or Letrozole or Exemestane</intervention_name>
    <description>Adjuvant chemotherapy + Anastrozole or Letrozole or Exemestane once a day for 5 years (concurrent arm)</description>
    <arm_group_label>ARM B</arm_group_label>
    <other_name>Experimental arm</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women with histological diagnosis of invasive breast cancer completely removed by
             surgery, any T, any N.

          -  Postmenopausal status defined by at least one of the following conditions:

               1. Aged ≥ 60

               2. Aged 45-59 and satisfying one or more of the following criteria:

                    -  amenorrhea for ≥12 months and intact uterus;

                    -  amenorrhea for &lt;12 months and follicle-stimulating hormone (FSH) within the
                       postmenopausal range, including:

                         -  pts with hysterectomy

                         -  pts who have received hormone replacement therapy (HRT)

                         -  pts with chemotherapy-induced amenorrhea

               3. bilateral oophorectomy at any age &gt;18 years.

          -  Primary tumor positive for Estrogen Receptors (ER) and/or Progesteron receptors (PgR)
             (≥1% tumor cells positive by immunohistochemistry or ≥ 10 fmol/mg cytosol protein by
             ligand binding assay).

          -  Patients who are prescribed 5 years of endocrine therapy with an aromatase inhibitors
             (AI)

          -  Indication for adjuvant chemotherapy- Patients with HER-2 positive tumors are eligible
             provided that they are prescribed trastuzumab according to registered schedule.

          -  Signed informed consent.

        Exclusion Criteria:

          -  HRT currently assumed or during the month before randomization

          -  Recurrent or metastatic disease

          -  HER-2 positive tumors if treatment with trastuzumab is considered not
             appropriate/feasible

          -  Concurrent illness that contraindicate adjuvant endocrine treatment and/or
             chemotherapy

          -  Patients who have received Tamoxifen as part of any breast cancer prevention trial

          -  Previous history of invasive breast cancer or other invasive malignancy within the
             previous 10 years, other than squamous or basal cell carcinoma of the skin or
             carcinoma in situ of the cervix, adequately cone biopsied

          -  Concomitant severe disease which would place the patient at unusual risk

          -  Concurrent treatment with experimental drugs

          -  Patients treated with systemic investigational drugs within the past 30 days
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lucia Del Mastro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lucia Del Mastro, MD</last_name>
    <phone>010 5558908</phone>
    <phone_ext>0039</phone_ext>
    <email>lucia.delmastro@hsanmartino.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ospedale Santo SpiritoH</name>
      <address>
        <city>Casale Monferrato</city>
        <state>AL</state>
        <zip>15033</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ospedale di Rete `Engles Profili` - A.S.U.R. Area Vasta 2</name>
      <address>
        <city>Fabriano</city>
        <state>AN</state>
        <zip>60044</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>A.O. San Giuseppe Moscati</name>
      <address>
        <city>Avellino</city>
        <state>AV</state>
        <zip>83100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe Colantuoni, MD</last_name>
      <phone>00390825203573</phone>
      <email>gicolantuoni@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Giuseppe Colantuoni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Tumori `Giovanni Paolo II` - IRCCS Ospedale Oncologico</name>
      <address>
        <city>Bari</city>
        <state>BA</state>
        <zip>70124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vito Lorusso, MD</last_name>
    </contact>
    <investigator>
      <last_name>Vito Lorusso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ASST Papa Giovanni XXIII - Ospedale Papa Giovanni XXIII</name>
      <address>
        <city>Bergamo</city>
        <state>BG</state>
        <zip>24127</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elena Rota Caremoli, MD</last_name>
      <phone>00390352673694</phone>
      <email>ecrota@hpg23.it</email>
    </contact>
    <investigator>
      <last_name>Elena Rota Caremoli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Treviglio-Caravaggio</name>
      <address>
        <city>Treviglio</city>
        <state>BG</state>
        <zip>24047</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sandro Treviglio, MD</last_name>
    </contact>
    <investigator>
      <last_name>Sandro Treviglio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera G. Rummo</name>
      <address>
        <city>Benevento</city>
        <state>BN</state>
        <zip>82100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincenza Tinessa, MD</last_name>
      <phone>0039082457721</phone>
      <email>vinenza.tinessa@libero.it</email>
    </contact>
    <investigator>
      <last_name>Vincenza Tinessa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Fatebenefratelli `Sacro Cuore di Gesù`</name>
      <address>
        <city>Benevento</city>
        <state>BN</state>
        <zip>82100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antonio Febbraro, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Antonio Febbraro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Presidio Ospedaliero `Antonio Perrino`</name>
      <address>
        <city>Brindisi</city>
        <state>BR</state>
        <zip>72100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saverio Cinieri, MD</last_name>
      <phone>00390831537219</phone>
      <email>saverio.cinieri@ieo.it</email>
    </contact>
    <investigator>
      <last_name>Saverio Cinieri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ASST Spedali Civili - P.O. Spedali Civili</name>
      <address>
        <city>Brescia</city>
        <state>BS</state>
        <zip>25123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Edda Lucia Simoncini, MD</last_name>
      <phone>00390303995260</phone>
      <email>edda.simoncini@spedalicivili.brescia.it</email>
    </contact>
    <investigator>
      <last_name>Edda Lucia Simoncini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile di Campobasso - A. Cardarelli</name>
      <address>
        <city>Campobasso</city>
        <state>CB</state>
        <zip>86100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ospedale Vietri</name>
      <address>
        <city>Larino</city>
        <state>CB</state>
        <zip>80035</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Carrozza, MD</last_name>
      <phone>00390874827216</phone>
      <email>carrozza_f@yahoo.it</email>
    </contact>
    <investigator>
      <last_name>Francesco Carrozza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Clinicizzato `S. Annunziata` - Università degli Studi `G. d'Annunzio`</name>
      <address>
        <city>Chieti</city>
        <state>CH</state>
        <zip>66100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clara Natoli, MD</last_name>
      <phone>00390871358004</phone>
      <email>natoli@unich.it</email>
    </contact>
    <investigator>
      <last_name>Clara Natoli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile Renzetti</name>
      <address>
        <city>Lanciano</city>
        <state>CH</state>
        <zip>66034</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucio Laudadio, MD</last_name>
      <phone>00390872706287</phone>
      <email>laudadio@oncologialanciano.it</email>
    </contact>
    <investigator>
      <last_name>Lucio Laudadio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile `Gaetano Bernabeo`</name>
      <address>
        <city>Ortona</city>
        <state>CH</state>
        <zip>66026</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clara Natoli, MD</last_name>
      <phone>00390871358004</phone>
      <email>natoli@unich.it</email>
    </contact>
    <investigator>
      <last_name>Clara Natoli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera S. Croce e Carle</name>
      <address>
        <city>Cuneo</city>
        <state>CN</state>
        <zip>12100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ornella Garrone, MD</last_name>
      <phone>00390171616350</phone>
      <email>ornella.garrone@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ornella Garrone, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ASST Lariana - Ospedale S. Anna</name>
      <address>
        <city>Como</city>
        <state>CO</state>
        <zip>22100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Giordano, MD</last_name>
      <phone>0039031555618</phone>
      <email>monicagiordano@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Monica Giordano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>﻿Humanitas Centro Catanese di Oncologia</name>
      <address>
        <city>Catania</city>
        <state>CT</state>
        <zip>95126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michele Caruso, MD</last_name>
    </contact>
    <investigator>
      <last_name>Michele Caruso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.)</name>
      <address>
        <city>Meldola</city>
        <state>FC</state>
        <zip>47014</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Rocca, MD</last_name>
      <phone>00390543739100</phone>
      <email>a.rocca@irst.emr.it</email>
    </contact>
    <investigator>
      <last_name>Andrea Rocca, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arcispedale S. Anna - A.O.U. di Ferrara</name>
      <address>
        <city>Cona</city>
        <state>FE</state>
        <zip>44124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Frassoldati, MD</last_name>
      <phone>00390532239209</phone>
      <email>a.frassoldati@ospfe.it</email>
    </contact>
    <investigator>
      <last_name>Antonio Frassoldati, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS `Casa Sollievo della Sofferenza`</name>
      <address>
        <city>San Giovanni Rotondo</city>
        <state>FG</state>
        <zip>71013</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evaristo Maiello, MD</last_name>
      <phone>00390882410640</phone>
      <email>e.maiello@libero.it</email>
    </contact>
    <investigator>
      <last_name>Evaristo Maiello, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.O.U. Careggi</name>
      <address>
        <city>Firenze</city>
        <state>FI</state>
        <zip>50134</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorenzo Livi, MD</last_name>
      <phone>00390557947264</phone>
      <email>lorenzo.livi@unifi.it</email>
    </contact>
    <investigator>
      <last_name>Lorenzo Livi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AUSL di Frosinone - Ospedale Fabrizio Spaziani</name>
      <address>
        <city>Frosinone</city>
        <state>FR</state>
        <zip>03100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Gamucci, MD</last_name>
      <phone>00390775882460</phone>
      <email>t.gamucci@libero.it</email>
    </contact>
    <investigator>
      <last_name>Teresa Gamucci, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AUSL di Frosinone - Ospedale SS. Trinità</name>
      <address>
        <city>Sora</city>
        <state>FR</state>
        <zip>03039</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Gamucci, MD</last_name>
      <phone>00390776829363</phone>
      <email>t.gamucci@libero.it</email>
    </contact>
    <investigator>
      <last_name>Teresa Gamucci, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</name>
      <address>
        <city>Genoa</city>
        <state>GE</state>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucia Del Mastro, MD</last_name>
      <phone>010 5558908</phone>
      <email>lucia.delmastro@hsanmartino.it</email>
    </contact>
    <investigator>
      <last_name>Lucia Del Mastro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matteo Lambertini, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>E.O. Ospedali Galliera</name>
      <address>
        <city>Genova</city>
        <state>GE</state>
        <zip>16128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea De Censi, MD</last_name>
      <phone>00390105634212</phone>
      <email>andrea.decensi@galliera.it</email>
    </contact>
    <investigator>
      <last_name>Andrea De Censi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda U.S.L. N. 9 - Ospedale Misericordia</name>
      <address>
        <city>Grosseto</city>
        <state>GR</state>
        <zip>58100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carmelo Bengala, MD</last_name>
    </contact>
    <investigator>
      <last_name>Carmelo Bengala, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Sanitaria Regionale Molise - Ospedale F. Veneziale - Zona di Isernia</name>
      <address>
        <city>Isernia</city>
        <state>IS</state>
        <zip>86170</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Liberato Di Lullo, MD</last_name>
    </contact>
    <investigator>
      <last_name>Liberato Di Lullo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Vito Fazzi</name>
      <address>
        <city>Lecce</city>
        <state>LE</state>
        <zip>73100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariangela Ciccarese, MD</last_name>
      <phone>00390832661962</phone>
      <email>m.ciccarese@libero.it</email>
    </contact>
    <investigator>
      <last_name>Mariangela Ciccarese, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.S.L. LT - Ospedale Santa Maria Goretti</name>
      <address>
        <city>Latina</city>
        <state>LT</state>
        <zip>04100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enzo Veltri, MD</last_name>
      <phone>003907736553840</phone>
      <email>e.veltri@ausl.latina.it</email>
    </contact>
    <investigator>
      <last_name>Enzo Veltri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Unico Versilia</name>
      <address>
        <city>Lido di Camaiore</city>
        <state>LU</state>
        <zip>55041</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Domenico Amoroso, MD</last_name>
      <phone>003905846057208</phone>
      <email>d.amoroso@usl12.toscana.it</email>
    </contact>
    <investigator>
      <last_name>Domenico Amoroso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale San Luca</name>
      <address>
        <city>Lucca</city>
        <state>LU</state>
        <zip>55100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>ASST Monza - Ospedale San Gerardo</name>
      <address>
        <city>Monza</city>
        <state>MB</state>
        <zip>20052</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ospedale di Macerata</name>
      <address>
        <city>Macerata</city>
        <state>MC</state>
        <zip>62100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emanuela Romagnoli, MD</last_name>
      <phone>003907332572556</phone>
      <email>emanuelaromagnoli@libero.it</email>
    </contact>
    <investigator>
      <last_name>Emanuela Romagnoli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ASST Melegnano e della Martesana - Ospedale Serbelloni</name>
      <address>
        <city>Gorgonzola</city>
        <state>MI</state>
        <zip>20064</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>ASST Ovest Milanese - Ospedale Nuovo di Legnano</name>
      <address>
        <city>Legnano</city>
        <state>MI</state>
        <zip>20025</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonella Ferzi, MD</last_name>
      <phone>0039 0331 449161</phone>
      <email>antonella.ferzi@ao-legnano.it</email>
    </contact>
    <investigator>
      <last_name>Antonella Ferzi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ASST Fatebenefratelli Sacco - Ospedale Fatebenefratelli e Oftalmico</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20121</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicla Maria La Verde, MD</last_name>
      <phone>0039026363223</phone>
      <email>nicla.laverde@fbf.milano.it</email>
    </contact>
    <investigator>
      <last_name>Nicla Maria La Verde, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Europeo di Oncologia (IRCCS)</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20141</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marco Angelo Colleoni, MD</last_name>
      <phone>00390294372733</phone>
      <email>marco.colleoni@ieo.it</email>
    </contact>
    <investigator>
      <last_name>Marco Angelo Colleoni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Carlo Poma</name>
      <address>
        <city>Mantova</city>
        <state>MN</state>
        <zip>46100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Giovanna Cavazzini, MD</last_name>
    </contact>
    <investigator>
      <last_name>Maria Giovanna Cavazzini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.O.U. Policlinico Modena</name>
      <address>
        <city>Modena</city>
        <state>MO</state>
        <zip>41124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Angela Toss, MD</last_name>
      <phone>00390594224334</phone>
      <email>angela.toss@unimore.it</email>
    </contact>
    <investigator>
      <last_name>Angela Toss, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.O.U. Policlinico `Paolo Giaccone`</name>
      <address>
        <city>Palermo</city>
        <state>PA</state>
        <zip>90129</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antonio Russo, MD</last_name>
    </contact>
    <investigator>
      <last_name>Antonio Russo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale `Guglielmo da Saliceto`</name>
      <address>
        <city>Piacenza</city>
        <state>PC</state>
        <zip>29121</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucia Cavanna, MD</last_name>
      <phone>00390523302140</phone>
      <email>l.cavanna@ausl.pc.it</email>
    </contact>
    <investigator>
      <last_name>Lucia Cavanna, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Oncologico Veneto - I.R.C.C.S.</name>
      <address>
        <city>Padova</city>
        <state>PD</state>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valentina Guarneri, MD</last_name>
      <phone>00390498215291</phone>
      <email>valentina.guarneri@unipd.it</email>
    </contact>
    <investigator>
      <last_name>Valentina Guarneri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile `San Massimo`</name>
      <address>
        <city>Penne</city>
        <state>PE</state>
        <zip>65017</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Donato Natale, MD</last_name>
    </contact>
    <investigator>
      <last_name>Donato Natale, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile di Città di Castello - A.S.L. n. 1</name>
      <address>
        <city>Città di Castello</city>
        <state>PG</state>
        <zip>06012</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stefano Bravi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Stefano Bravi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Maria della Misericordia</name>
      <address>
        <city>Perugia</city>
        <state>PG</state>
        <zip>06132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucio Crinò, MD</last_name>
      <phone>00390755784209</phone>
      <email>lcrino@unipg.it</email>
    </contact>
    <investigator>
      <last_name>Lucio Crinò, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.O.U. Pisana - Ospedale Santa Chiara</name>
      <address>
        <city>Pisa</city>
        <state>PI</state>
        <zip>56126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alfredo Falcone, MD</last_name>
    </contact>
    <investigator>
      <last_name>Alfredo Falcone, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Felice Lotti - Azienda USL 5 di Pisa</name>
      <address>
        <city>Pontedera</city>
        <state>PI</state>
        <zip>56025</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giacomo Allegrini, MD</last_name>
      <phone>00390587273104</phone>
      <email>g.allegrini@usl5.toscana.it</email>
    </contact>
    <investigator>
      <last_name>Giacomo Allegrini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico Umberto I</name>
      <address>
        <city>Roma</city>
        <state>PM</state>
        <zip>00186</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ersilia Ranieri, MD</last_name>
    </contact>
    <investigator>
      <last_name>Ersilia Ranieri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria di Parma</name>
      <address>
        <city>Parma</city>
        <state>PR</state>
        <zip>43100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrea Ardizzoni, MD</last_name>
    </contact>
    <investigator>
      <last_name>Andrea Ardizzoni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Santa Croce - A.O. Ospedali Riuniti Marche Nord</name>
      <address>
        <city>Fano</city>
        <state>PS</state>
        <zip>61032</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rodolfo Mattioli, MD</last_name>
      <phone>00390721882397</phone>
      <email>rodolfo.mattioli@ospedalimarchenord.it</email>
    </contact>
    <investigator>
      <last_name>Rodolfo Mattioli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione S. Maugeri IRCCS</name>
      <address>
        <city>Pavia</city>
        <state>PV</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Bernardo, MD</last_name>
      <phone>00390382592640</phone>
      <email>antonio.bernardo@fsm.it</email>
    </contact>
    <investigator>
      <last_name>Antonio Bernardo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera S. Carlo</name>
      <address>
        <city>Potenza</city>
        <state>PZ</state>
        <zip>85100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Domenico Bilancia, MD</last_name>
    </contact>
    <investigator>
      <last_name>Domenico Bilancia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale per gli Infermi</name>
      <address>
        <city>Faenza</city>
        <state>RA</state>
        <zip>48018</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Amaducci, MD</last_name>
      <phone>00390546601196</phone>
      <email>l.amaducci@ausl.ra.it</email>
    </contact>
    <investigator>
      <last_name>Laura Amaducci, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Umberto I</name>
      <address>
        <city>Lugo</city>
        <state>RA</state>
        <zip>48022</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefano Tamberi, MD</last_name>
      <phone>00390545214084</phone>
      <email>ste.tamberi@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Stefano Tamberi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Bianchi - Melacrino - Morelli</name>
      <address>
        <city>Reggio Calabria</city>
        <state>RC</state>
        <zip>89125</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mario Nardi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Mario Nardi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale San Sebastiano</name>
      <address>
        <city>Correggio</city>
        <state>RE</state>
        <zip>42015</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alessandra Zoboli, MD</last_name>
      <phone>00390522630308</phone>
      <email>zobolia@ausl.re.it</email>
    </contact>
    <investigator>
      <last_name>Alessandra Zoboli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile di Guastalla</name>
      <address>
        <city>Guastalla</city>
        <state>RE</state>
        <zip>42016</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Scaltriti, MD</last_name>
      <phone>00390522837217</phone>
      <email>laura.scaltriti@ausl.re.it</email>
    </contact>
    <investigator>
      <last_name>Laura Scaltriti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS A.O. S.Maria Nuova</name>
      <address>
        <city>Reggio Emilia</city>
        <state>RE</state>
        <zip>42123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giancarlo Bisagni</last_name>
      <phone>00390522296628</phone>
      <email>bisagni.giancarlo@asmn.re.it</email>
    </contact>
    <investigator>
      <last_name>Giancarlo Bisagni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Regina Elena per lo studio e la cura dei tumori</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00144</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Cognetti, MD</last_name>
      <phone>00390652665453</phone>
      <email>cognetti@ifo.it</email>
    </contact>
    <investigator>
      <last_name>Francesco Cognetti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Eugenio</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00144</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mauro Minelli, MD</last_name>
    </contact>
    <investigator>
      <last_name>Mauro Minelli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera San Camillo - Forlanini</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00149</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anna Maria Parisi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Anna Maria Parisi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Fatebenefratelli San Giovanni Calibita - Isola Tiberina</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00186</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Angelo Fedele Scinto, MD</last_name>
    </contact>
    <investigator>
      <last_name>Angelo Fedele Scinto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.O. S. Andrea - Università `La Sapienza` - II Facoltà di Medicina e Chirurgia</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00189</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paolo Marchetti, MD</last_name>
    </contact>
    <investigator>
      <last_name>Paolo Marchetti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera n. 1 - Annunziata</name>
      <address>
        <city>Sassari</city>
        <state>SS</state>
        <zip>07100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Pazzola, MD</last_name>
      <phone>00390792061556</phone>
      <email>oncologia.medica@aslsassari.it</email>
    </contact>
    <investigator>
      <last_name>Antonio Pazzola, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione del Piemonte per l'Oncologia - IRCC di Candiolo</name>
      <address>
        <city>Candiolo</city>
        <state>TO</state>
        <zip>10060</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Filippo Montemurro, MD</last_name>
      <phone>﻿00390119933250</phone>
      <email>filippo.montemurro@ircc.it</email>
    </contact>
    <investigator>
      <last_name>Filippo Montemurro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Anna - A.O.U. Città della Salute e della Scienza</name>
      <address>
        <city>Torino</city>
        <state>TO</state>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antonio Durando, MD</last_name>
      <phone>0039 011 3135702</phone>
      <email>antoniodurando@libero.it</email>
    </contact>
    <investigator>
      <last_name>Antonio Durando, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Anna - Città della salute</name>
      <address>
        <city>Torino</city>
        <state>TO</state>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>ASST della Valle Olona - Ospedale di Saronno</name>
      <address>
        <city>Saronno</city>
        <state>VA</state>
        <zip>21047</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudio Verusio, MD</last_name>
      <phone>0039029613576</phone>
      <email>cverusio@aobusto.it</email>
    </contact>
    <investigator>
      <last_name>Claudio Verusio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Sacro Cuore Don Calabria</name>
      <address>
        <city>Negrar</city>
        <state>VE</state>
        <zip>37024</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefania Gori, MD</last_name>
      <phone>00390456013472</phone>
      <email>stefania.gori@sacrocuore.it</email>
    </contact>
    <investigator>
      <last_name>Stefania Gori, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Belcolle - AUSL di Viterbo</name>
      <address>
        <city>Viterbo</city>
        <state>VT</state>
        <zip>01100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enzo Maria Ruggeri, MD</last_name>
      <phone>00390761339043</phone>
      <email>ruggeriem@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Enzo Maria Ruggeri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.O.U. Federico II</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabino De Placido, MD</last_name>
      <phone>00390817463650</phone>
      <email>studiclinici.oncologia@unina.it</email>
    </contact>
    <investigator>
      <last_name>Sabino De Placido, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera `A. Cardarelli` (AORN)</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ferdinando Riccardi, MD</last_name>
      <phone>00390817472174</phone>
      <email>nando.riccardi@alice.it</email>
    </contact>
    <investigator>
      <last_name>Ferdinando Riccardi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Nazionale dei Tumori - Fondazione G.Pascale</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelino De Laurentiis, MD</last_name>
      <phone>00390815454999</phone>
      <email>m.delaurentiis@breastunit.org</email>
    </contact>
    <investigator>
      <last_name>Michelino De Laurentiis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2016</study_first_submitted>
  <study_first_submitted_qc>September 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 28, 2016</study_first_posted>
  <last_update_submitted>November 3, 2017</last_update_submitted>
  <last_update_submitted_qc>November 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</investigator_affiliation>
    <investigator_full_name>Lucia Del Mastro,MD</investigator_full_name>
    <investigator_title>Director of S.S. Innovative Therapies Unit</investigator_title>
  </responsible_party>
  <keyword>sequential administration chemiotherapy</keyword>
  <keyword>early breast cancer</keyword>
  <keyword>breast cancer</keyword>
  <keyword>aromatase inhibitor</keyword>
  <keyword>adjuvant</keyword>
  <keyword>post menopausal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Letrozole</mesh_term>
    <mesh_term>Exemestane</mesh_term>
    <mesh_term>Anastrozole</mesh_term>
    <mesh_term>Aromatase Inhibitors</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

